(Q48701158)

English

Minimal supportive treatment in natalizumab-related PML in a MS patient

scientific article published on 23 June 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Minimal supportive treatment in natalizumab-related PML in a MS patient (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Renaud Du Pasquier

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Frederik Barkhof

6

object named as

Frederik Barkhof

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

author name string

Patrice H Lalive

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Claire Bridel

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Ruxandra Iancu Ferfoglia

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Laurent Kaiser

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

language of work or name

0 references

publication date

23 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

86

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

354-355

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308154

21 January 2018

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308154

21 January 2018

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308154

21 January 2018

Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308154

21 January 2018

Identifiers

10.1136/JNNP-2014-308154

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24957322

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48701158&oldid=2207275377"